Avadel Pharmaceuticals PLC AVDL
$21.64 $0.01 (0.05%) 1D
Last Updated: Feb 11, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
AVDL Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Avadel Pharmaceuticals PLC is classified as halal.
HALAL
Report Source: undefined Quarter Report
Avadel Pharmaceuticals PLC. Stock Analysis AVDL
United States Health Care Mid Cap Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. The company is headquartered in Dublin, Dublin and currently employs 188 full-time employees. The firm's product, LUMRYZ, is an extended-release formulation of sodium oxybate, indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the challenges patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME, and MEDUSA. Its MICROPUMP technology allows for the development of modified-release solid, oral dosage formulations of drugs. Its LIQUITIME technology allows for the development of modified-release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its MEDUSA technology allows for the development of modified-release injectable dosage formulations of drugs.
Avadel Pharmaceuticals PLC (AVDL) Chart
Financial Metrics & Statements of Avadel Pharmaceuticals PLC (AVDL)
FAQ's for Avadel Pharmaceuticals PLC (AVDL)
- As of August 2026, Avadel Pharmaceuticals PLC AVDL is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Avadel Pharmaceuticals PLC using these criteria to determine its compliance status.
- Muslim investors may consider investing in Avadel Pharmaceuticals PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Avadel Pharmaceuticals PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Avadel Pharmaceuticals PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Avadel Pharmaceuticals PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Avadel Pharmaceuticals PLC (AVDL)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
